The U.S. Centers for Disease Control and Prevention (CDC) has launched an investigation into reports of botulism-like illnesses in several states linked to botulinum toxin injections, commonly known as ‘Botox,’ administered in non-medical settings. The CDC is coordinating a multi-state outbreak investigation in response to these concerning reports.

Illnesses have been reported in Tennessee and Illinois, prompting the involvement of the respective state health departments, as well as the Food and Drug Administration (FDA) in collaboration with the CDC. In Tennessee, four patients sought medical care after experiencing ‘botulism-like signs and symptoms’ following cosmetic Botox injections, with two of them requiring hospitalization.

Authorities have cautioned against seeking Botox injections from unlicensed providers or in non-medical settings, emphasizing the potential dangers associated with counterfeit products or products of unclear origin. The Illinois Department of Public Health issued a statement after two patients reported symptoms, such as blurred/double vision, droopy face, fatigue, difficulty breathing, shortness of breath, and hoarse voice, following potentially counterfeit Botox injections in LaSalle County.

Botulism, a serious and sometimes fatal illness, occurs when a toxin attacks the body’s nerves. The CDC has highlighted the unknown or unverified sources of these botulinum toxin products and directed inquiries about product regulation and investigation to the FDA. Additional cases have been reported in Kentucky, Washington, and Colorado, raising further concerns about the safety and origins of the implicated products.

As the investigation unfolds, the CDC’s efforts aim to address the risks associated with non-medical administration of Botox and to raise awareness about the potential dangers posed by counterfeit or unregulated products. The public is urged to exercise caution and seek Botox treatments only from licensed medical professionals operating in authorized medical settings.